benzoapyrene phase 2 glutathione s transferase Frontiers Benzo[a]pyrene (BaP) metabolites predominant in
Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro dosing with [14C] BaP ScienceDirect Benzo[a]pyrene and Caenorhabditis elegans: defining the genotoxic potential in an organism lacking the classical CYP1A1 pathway Archives of Toxicology Springer Nature Link Benzo(a)pyrene and cardiovascular diseases: An overview of pre clinical studies focused on the underlying molecular mechanism Frontiers Modulation of Glutathione S Transferase by Phytochemicals: To Activate or InhibitThat Is the Question
Pay in 4 interest-free payments of $6.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
![benzoapyrene phase 2 glutathione s transferase Frontiers Benzo[a]pyrene (BaP) metabolites predominant in](https://ars.els-cdn.com/content/image/1-s2.0-S016041202100670X-ga1.jpg)
![benzoapyrene phase 2 glutathione s transferase Frontiers Benzo[a]pyrene (BaP) metabolites predominant in](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00204-020-02968-z/MediaObjects/204_2020_2968_Fig7_HTML.png)
![benzoapyrene phase 2 glutathione s transferase Frontiers Benzo[a]pyrene (BaP) metabolites predominant in](https://www.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/978475/fnut-09-978475-HTML/image_m/fnut-09-978475-g001.jpg)
![benzoapyrene phase 2 glutathione s transferase Frontiers Benzo[a]pyrene (BaP) metabolites predominant in](https://www.mdpi.com/ijms/ijms-26-07202/article_deploy/html/images/ijms-26-07202-g001-550.jpg)